Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Carica Papaya in Dengue Fever
NCT06121934Phase 3Completed
- Sponsor
- Bangabandhu Sheikh Mujib Medical University
- Start
- Oct 2023
- Primary completion
- Dec 2023
- Modality
- PE (Plant Extract)
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in dengue fever comparing Carica Papaya Leaf Extract with Placebo (2 arms). Primary endpoints: Rise in platelet counts at 5 days and Return of hematocrit levels towards baseline at 5 days. Started Oct 2023; status: completed.
02
Drugs
carica papaya leaf extract
03
Conditions
dengue fever
Beyond the preview
Go deeper on NCT06121934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06121934.